(Q50313358)

2 March 2018

title

Autism and Schizophrenia: Intestinal Disorders. (English)

1 reference

2 March 2018

0 references

0 references

R Cade

1

1 reference

2 March 2018

M Privette

2

1 reference

2 March 2018

M Fregly

3

1 reference

2 March 2018

N Rowland

4

1 reference

2 March 2018

Z Sun

5

1 reference

2 March 2018

V Zele

6

1 reference

2 March 2018

H Wagemaker

7

1 reference

2 March 2018

C Edelstein

8

1 reference

2 March 2018

publication date

1 January 2000

1 reference

2 March 2018

published in

Nutritional Neuroscience

1 reference

2 March 2018

volume

3

1 reference

2 March 2018

issue

1

1 reference

2 March 2018

page(s)

57-72

1 reference

2 March 2018

Abnormal intestinal permeability in children with autism

cites work

1 reference

https://api.crossref.org/works/10.1080%2F1028415X.2000.11747303

Cereals and schizophrenia data and hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1028415X.2000.11747303

Relapsed Schizophrenics: Earlier Discharge from the Hospital After Cereal-Free, Milk-Free Diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1028415X.2000.11747303

Malabsorption and cerebral dysfunction: A multivariate and comparative study of autistic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1028415X.2000.11747303

A peptide-containing fraction in the urine of schizophrenic patients which stimulates opiate receptors and inhibits dopamine uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1028415X.2000.11747303

Enkephalin-containing polypeptides are potent inhibitors of enkephalin degradation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1028415X.2000.11747303

Passage of undegraded dietary antigen into the blood of healthy adults. Quantification, estimation of size distribution, and relation of uptake to levels of specific antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1028415X.2000.11747303

Autistic Syndromes and Diet: a follow‐up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1028415X.2000.11747303

Epilepsy in autism and autisticlike conditions. A population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1028415X.2000.11747303

Endogenous opioids and social behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1028415X.2000.11747303

A neurochemical theory of autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1028415X.2000.11747303

Serum IgA antibodies from patients with coeliac disease react strongly with human brain blood-vessel structures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1028415X.2000.11747303

Childhood autism: a complex disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1028415X.2000.11747303

Peptide excretion in celiac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1028415X.2000.11747303

A Peptide Found in Schizophrenia and Autism Causes Behavioral Changes in Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1028415X.2000.11747303

Patterns of peptides and protein-associated-peptide complexes in psychiatric disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1028415X.2000.11747303

Seizure disorders in autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1028415X.2000.11747303

10.1080/1028415X.2000.11747303

21 January 2018

Identifiers

DOI

1 reference

2 March 2018

PubMed ID

27416160

1 reference

2 March 2018